市場調查報告書
商品編碼
1422958
2024-2032 年 G 蛋白偶聯受體市場(按產品、檢測類型、應用和地區分類)G-Protein Coupled Receptors Market by Product, Assay Type, Application, and Region 2024-2032 |
2023年全球G蛋白偶聯受體(GPCR)市場規模達34億美元。展望未來, IMARC Group預計到2032年市場規模將達到57億美元,2024年複合年成長率(CAGR)為5.69% 2032. GPCR 在藥物發現中的日益採用、癌症病例數量的增加以及廣泛的研發 (R&D) 活動是推動市場發展的一些關鍵因素。
G蛋白偶聯受體(GPCR)是人類基因組編碼的最大的蛋白質家族。它們是訊號傳導分子,將訊號傳遞給細胞,並在將細胞外刺激轉化為細胞內反應方面發揮關鍵作用。它們位於細胞膜中,負責所有生理過程。 GPCR 是細胞表面受體,其作用類似於脂質、糖、光能、胜肽和蛋白質形式的訊息收件匣。這些受體廣泛用於治療各種疾病,例如發炎性疾病、代謝失衡、心臟病、癌症和單基因疾病。因此,GPCR 也存在於多種生物體的細胞膜中,包括哺乳動物、植物、微生物和無脊椎動物。
全球藥物發現中擴大採用 GPCR 是推動市場成長的關鍵因素之一。與此一致的是,由於癌症病例和心血管感染和呼吸困難等與生活方式相關的疾病數量不斷增加,GPCR在新型藥物開發中的廣泛應用有利於市場成長。此外,GPCR 在多種生理過程中已廣泛應用,因為它們位於細胞表面,並且可以被多種化學或生物製劑調節,因此可以作為另一種生長誘導因子。除此之外,將自動化和創新技術與藥物開發篩選程序結合,以提高其治療生產能力,這也為市場成長提供了動力。此外,有效藥物發現方法的重大發展,例如簡化受體結構和新藥配方的計算方法的進步,正在推動市場成長。此外,GPCR 在腫瘤學和癌症生物學各個方面(如侵襲、遷移和血管重塑)的廣泛採用,為市場成長提供了相當大的推動力。除此之外,擴大利用 GPCR 來解碼腫瘤的轉移和生長並開發有效的治療方案,對市場成長產生了積極影響。其他因素,包括廣泛的研發(R&D)活動、各種自動化改進、環磷酸腺苷(cAMP)的廣泛採用以及政府在生物技術和生物製藥領域實施的各種舉措預計將推動市場成長。
The global G-protein coupled receptors (GPCRs) market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.69% during 2024-2032. The increasing adoption of GPCRs in drug discovery, the rising number of cancer cases, and extensive research and development (R&D) activities represent some of the key factors driving the market.
G-protein-coupled receptors (GPCRs) are the largest protein family encoded by the human genome. They are signal-transducing molecules that transmit signals to cells and play a key role in converting an extracellular stimulus into intracellular responses. They are located in the cell membrane and are responsible for all physiological processes. GPCRs are cell surface receptors that act like an inbox for messages in the form of lipids, sugars, light energy, peptides, and proteins. These receptors are widely used in the treatment of various diseases, such as inflammatory disorders, metabolic imbalances, cardiac disorders, cancer, and monogenic disorders. As a result, GPCRs are also found in the cell membranes of several organisms, including mammals, plants, microorganisms, and invertebrates.
The increasing adoption of GPCRs in drug discovery across the globe is one of the key factors driving the market growth. In line with this, the widespread utilization of GPCRs in the development of novel pharmaceuticals due to the rising number of cancer cases and lifestyle-related diseases, such as cardiovascular infections and respiratory difficulties, are favoring the market growth. Moreover, the extensive application of GPCRs in several physiological processes as they can be modulated by a wide range of chemical or biological agents due to their cell-surface location is acting as another growth-inducing factor. Apart from this, the integration of automation and innovative technologies with drug development screening procedures to improve their capabilities in therapeutic production is providing an impetus to the market growth. Furthermore, significant developments in effective drug discovery methods, such as advancements in the computational approaches to streamline receptor structure and formulation of new drugs, are propelling the market growth. Additionally, the widespread adoption of GPCRs in oncology and various aspects of cancer biology, such as invasion, migration, and vascular remolding, is providing a considerable boost to the market growth. Besides this, the increasing utilization of GPCRs for decoding metastasis and growth of tumors and developing effective lines of treatment is positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, various automation improvements, the widespread adoption of cyclic Adenosine Monophosphate (cAMP), and the implementation of various government initiatives in the biotechnology and biopharmaceutical sector are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global G-protein coupled receptors (GPCRs) market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, assay type, and application.
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the product. This includes cell lines, detection kits, cell culture reagents and ligands. According to the report, cell lines represented the largest segment.
cAMP Functional Assays
Calcium Functional Assays
B-Arrestin Functional Assays
Radioligand Binding and GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Others
The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the assay type. This includes cAMP functional, calcium functional, B-Arrestin functional, radioligand binding and GTPγS functional, internalization, and trafficking assays. According to the report, cAMP functional assays represented the largest segment.
Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Inflammation Research
Respiratory Research
Others
The report has provided a detailed breakup and analysis of the G-protein coupled receptors (GPCRs) market based on the application. This includes cancer, CNS, metabolic, cardiovascular, inflammation, respiratory research, and others. According to the report, cancer research represented the largest segment.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for G-protein coupled receptors (GPCRs). Some of the factors driving the North America G-protein coupled receptors (GPCRs) market included rising number of cancer cases, extensive research and development (R&D) activities, and various automation improvements.
The report has also provided a comprehensive analysis of the competitive landscape in the global G-protein coupled receptors (GPCRs) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Becton Dickinson and Company, Enzo Biochem Inc., Eurofins DiscoverX Products LLC, HD Biosciences Co. Ltd. (WuXi AppTec), Merck KGaA, Molecular Devices LLC (Danaher Corporation), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., etc.